OpenBilldrug price receipt

NADAC week of 2026-10-14

CYCLOBENZAPRINE 10 MG TABLET

For 30 tablets

Pharmacies pay

$0.51 filed

30 × $0.01712 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.26 filed

30 × $0.14207 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

8.3× estimated

Medicare paid 8.3× what pharmacies pay.

Part D averages every strength and form sold under “Cyclobenzaprine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.59 estimated

$0.51 + $0.08 (15%) + $5.00 fee per fill = $5.59

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CYCLOBENZAPRINE 10 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “cyclobenzaprine” and “cyclobenzaprine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 16 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and KVK-TECH, Inc.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under 43 NDCs (National Drug Codes); the FDA directory lists 41 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.51 for 30 tablets (30 × $0.01712 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 16 labelers

LabelerNDCsPharmacies pay per unit
EXELAN PHARMACEUTICALS, INC.6$0.01712 per EA filed
Rising Pharma Holdings, Inc.6$0.01712 per EA filed
Advagen Pharma Limited3$0.01712 per EA filed
NORTHSTAR RX LLC3$0.01712 per EA filed
Solco Healthcare U.S., LLC3$0.01712 per EA filed
Teva Pharmaceuticals USA, Inc.3$0.01712 per EA filed
TruPharma LLC3$0.01712 per EA filed
Unichem Pharmaceuticals (USA), Inc.3$0.01712 per EA filed
Cipla USA Inc.2$0.01712 per EA filed
Jubilant Cadista Pharmaceuticals Inc.2$0.01712 per EA filed
KVK-TECH, Inc.2$0.01712 per EA filed
American Health Packaging1$0.01712 per EA filed
Aurobindo Pharma Limited1$0.01712 per EA filed
AvPAK1$0.01712 per EA filed
Major Pharmaceuticals1$0.01712 per EA filed
SOLA Pharmaceuticals, LLC1$0.01712 per EA filed
Not listed as a package in the FDA directory2$0.01712 per EA filed
All 43 NDCs, with labeler and price
  • 00093-3422-01 · Teva Pharmaceuticals USA, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 00093-3422-05 · Teva Pharmaceuticals USA, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 00093-3422-10 · Teva Pharmaceuticals USA, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 00904-7401-61 · Major Pharmaceuticals · $0.01712 per EA · eff. 2026-09-23 filed
  • 10702-0007-10 · KVK-TECH, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 10702-0007-50 · KVK-TECH, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 16571-0783-01 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 16571-0783-10 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 16571-0783-50 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 29300-0415-01 · Unichem Pharmaceuticals (USA), Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 29300-0415-10 · Unichem Pharmaceuticals (USA), Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 29300-0415-19 · Unichem Pharmaceuticals (USA), Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 43547-0400-10 · Solco Healthcare U.S., LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 43547-0400-11 · Solco Healthcare U.S., LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 43547-0400-50 · Solco Healthcare U.S., LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 50268-0191-11 · not listed as a package in the FDA directory · $0.01712 per EA · eff. 2026-09-23 filed
  • 50268-0191-15 · AvPAK · $0.01712 per EA · eff. 2026-09-23 filed
  • 52817-0332-00 · TruPharma LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 52817-0332-10 · TruPharma LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 52817-0332-50 · TruPharma LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 59746-0177-06 · Jubilant Cadista Pharmaceuticals Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 59746-0177-10 · Jubilant Cadista Pharmaceuticals Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 60687-0558-01 · American Health Packaging · $0.01712 per EA · eff. 2026-09-23 filed
  • 60687-0558-11 · not listed as a package in the FDA directory · $0.01712 per EA · eff. 2026-09-23 filed
  • 64980-0657-01 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 64980-0657-10 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 64980-0657-50 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 65862-0191-05 · Aurobindo Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
  • 69097-0846-07 · Cipla USA Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 69097-0846-15 · Cipla USA Inc. · $0.01712 per EA · eff. 2026-09-23 filed
  • 70512-0872-10 · SOLA Pharmaceuticals, LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 72603-0312-01 · NORTHSTAR RX LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 72603-0312-02 · NORTHSTAR RX LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 72603-0312-03 · NORTHSTAR RX LLC · $0.01712 per EA · eff. 2026-09-23 filed
  • 72888-0014-00 · Advagen Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
  • 72888-0014-01 · Advagen Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
  • 72888-0014-05 · Advagen Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
  • 76282-0283-10 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
  • 76282-0283-18 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
  • 76282-0283-27 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
  • 76282-0283-30 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
  • 76282-0283-60 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
  • 76282-0283-90 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

8 other products in the NADAC file share an FDA nonproprietary name with CYCLOBENZAPRINE 10 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
AMRIX ER 15 MG CAPSULE
brand · capsule, extended release
$66.23256 per EA filed
eff. 2026-01-01
We don’t know yet
AMRIX ER 30 MG CAPSULE
brand · capsule, extended release
$66.56709 per EA filed
eff. 2026-01-01
We don’t know yet
CYCLOBENZAPRINE 5 MG TABLET
generic · tablet, film coated / tablet
$0.02197 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE 7.5 MG TABLET
generic · tablet, film coated
$0.26288 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE 10 MG TABLET this page
generic · tablet, film coated / tablet
$0.01712 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE ER 15 MG CAP
generic · capsule, extended release
$1.18556 per EA filed
eff. 2026-09-23
We don’t know yet
CYCLOBENZAPRINE ER 30 MG CAP
generic · capsule, extended release
$1.0822 per EA filed
eff. 2026-09-23
We don’t know yet
FEXMID 7.5 MG TABLET
generic · tablet
$0.26288 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
TONMYA 2.8 MG TABLET SL
brand · tablet, orally disintegrating
$29.60952 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 43 NDCs’ NADAC prices is $0.01712 per EA filed.

Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 22 have a higher middle NADAC price and 0 a lower one. The one in the middle is CHLORZOXAZONE 375 MG TABLET, at $0.66652 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $4.26 for 30 tablets, at an average of $0.14207 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cyclobenzaprine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 7,401,986 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CYCLOBENZAPRINE 10 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cyclobenzaprine HCl / Cyclobenzaprine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.